Clinical Challenges: CAR T-Cell Therapy in Multiple Myeloma

(MedPage Today) -- The advent of next-generation proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies over the last decade has revolutionized the way patients with multiple myeloma are managed.
However, the disease remains...